Artivion | CRY - Interest Expense On Debt


Artivion reported $5.53M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Abbott USD 299M 231M Jun/2026
Accuray USD 2.88M 72K Dec/2024
AngioDynamics USD 102K 2K Sep/2025
Artivion USD 5.53M 589K Dec/2025
AtriCure USD 1.21M 159K Mar/2026
Baxter International USD 78M 20M Mar/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Boston Scientific USD 96M 6M Jun/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Inogen 1.03M 384K Mar/2025
Integra LifeSciences USD 22.99M 529K Jun/2026
J&J USD 43M 25M Mar/2026
Mesa Laboratories USD 3.02M 180K Sep/2024
Orthofix International 4.68M 731K Sep/2025
Pfizer USD 667M 4M Jun/2026
ResMed USD 8.79M 14.55M Sep/2025
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 27.95M 2.24M Jun/2026
Terumo JPY 1.48B 51M Jun/2026
Trinity Biotech USD 3.33M 50K Sep/2025